CollPlant Biotechnologies Ltd (CLGN) › Capital ExpendituresCollPlant Biotechnologies Ltd (CLGN) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2018: $832.0K2019: $1.49M2020: $437.0K2021: $1.43M2022: $1.27M2023: $954.0K2024: $483.0K2025: $28.0K$28.0K2018Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$28.0K-94.2%2024$483.0K-49.4%2023$954.0K-25.1%2022$1.27M-10.8%2021$1.43M+226.8%2020$437.0K-70.7%2019$1.49M+79.2%2018$832.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share